High Uric Acid Decrease the Number of Erections in Night: A Propensity Score-Matched Analysis
Urology Journal,
Vol. 22 No. 03 (2025),
9 September 2025
,
Page 156-163
https://doi.org/10.22037/uj.v22i.8263
Abstract
Background: Metabolic syndrome is considered a risk predictor for erection dysfunction (ED). However, the effect of serum uric acid (UA) on the development of ED is little known.
Methods: We adopt propensity score matching analysis (PSM) to adjust multitudinous confounding factors such as age, metabolic syndrome, sex hormone and some blood measurements. The members of the normal UA and high UA participator were matched at a 1:1 ratio by propensity score. And we used two diagnostic methods IIEF-5 and nocturnal penile tumescence and rigidity (NPTR) to assess and diagnose ED.
Results: Before PSM, total 120 participators were included, compared with participants with normal serum UA (n=61), those with high serum UA(n=59) had statistic difference in some baseline information (BMI 27.8 ± 7.4 vs 24.4 ± 5.1 kg/m2, p = 0.004; TG 2.1 ± 1.8 vs 1.5 ± 0.9 mmol/L, p = 0.015; creatinine 70.5 ± 9.9 vs 66.3 ± 10.7 umol/L, p = 0.03; T 450.9 ± 181.0 vs 598.2 ± 186.3 ng/dL, p < 0.001). After PSM, total 82 participators were included, with high level of serum UA (n = 41, Group A) and normal serum UA (n = 41, Group B). On the result of IIEF-5, 40 of 41 participants (97.6.0%) with high UA diagnosed ED, whereas 39 of 41 participants (95.1%) with normal UA diagnosed ED, the incidence has no statistical significance between two groups (p > 0.999). On the result of NPTR, the mean number of erections in Group A was 4.1 ± 2.0, was significantly less than the same parameter in Group B (5.3 ± 1.9, p = 0.004); 9 of 41 participants (22.0%) with high UA develop ED, whereas 14 of 41 participants (34.1%) with normal UA develop ED, the incidence has no statistical significance between Group A and Group B (p = 0.326).
Conclusions: Our study revealed that high UA did decrease the number of erections in night, which was diagnosed by NPTR. High uric acid may be a potential risk factor for ED and more large studies are needed.
- Erection dysfunction
- IIEF-5
- NPTR
- Propensity
How to Cite
References
Mccabe MP, Sharlip ID, Atalla E, Balon R, Fisher AD, Laumann E, et al. Definitions of Sexual Dysfunctions in Women and Men: A Consensus Statement From the Fourth International Consultation on Sexual Medicine 2015. J Sex Med 2016, 13(2): 135-143.
Nicolosi A, Moreira EJ, Shirai M, Bin MTM, Glasser DB. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003, 61(1): 201-206.
Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006, 166(2): 207-212.
Mckinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000, 12 Suppl 4: S6-S11.
Inman BA, Sauver JL, Jacobson DJ, Mcgree ME, Nehra A, Lieber MM, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc 2009, 84(2): 108-113.
Shiri R, Koskimäki J, Hakama M, Häkkinen J, Huhtala H, Tammela TL, et al. Effect of life-style factors on incidence of erectile dysfunction. Int J Impot Res 2004, 16(5): 389-394.
Batty GD, Li Q, Czernichow S, Neal B, Zoungas S, Huxley R, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol 2010, 56(23): 1908-1913.
Skrypnik D, Bogdański P, Musialik K. [Obesity--significant risk factor for erectile dysfunction in men]. Pol Merkur Lekarski 2014, 36(212): 137-141.
Najari BB, Kashanian JA. Erectile Dysfunction. JAMA 2016, 316(17): 1838.
Koroglu G, Kaya-Sezginer E, Yilmaz-Oral D, Gur S. Management of Erectile Dysfunction: An Under-Recognition of Hypertension. Curr Pharm Des 2018, 24(30): 3506-3519.
Miner M, Billups KL. Erectile dysfunction and dyslipidemia: relevance and role of phosphodiesterase type-5 inhibitors and statins. J Sex Med 2008, 5(5): 1066-1078.
Kouidrat Y, Pizzol D, Cosco T, Thompson T, Carnaghi M, Bertoldo A, et al. High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies. Diabet Med 2017, 34(9): 1185-1192.
Wu YX, Yang CT, Li N, Zheng X, Li X, Zhang H, et al. How Does Diabetes Impair Penile Tissues during Erectile Dysfunction? Endocr Metab Immune Disord Drug Targets 2020, 20(9): 1535-1542.
Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ. Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complications 2011, 25(2): 129-136.
Chitaley K, Kupelian V, Subak L, Wessells H. Diabetes, obesity and erectile dysfunction: field overview and research priorities. J Urol 2009, 182(6 Suppl): S45-S50.
Blute M, Hakimian P, Kashanian J, Shteynshluyger A, Lee M, Shabsigh R. Erectile dysfunction and testosterone deficiency. Front Horm Res 2009, 37: 108-122.
Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67(5): 1739-1742.
Park JH, Jin YM, Hwang S, Cho DH, Kang DH, Jo I. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide 2013, 32: 36-42.
Matheus AS, Tibiriçá E, Da SP, de Fátima BDMM, Gomes MB. Uric acid levels are associated with microvascular endothelial dysfunction in patients with Type 1 diabetes. Diabet Med 2011, 28(10): 1188-1193.
Totaro M, Dimarakis S, Castellini C, D'Andrea S, Parisi A, D'Amato F, et al. Erectile dysfunction in hyperuricemia: A prevalence meta-analysis and meta-regression study. Andrology-Us 2021.
Wu X, Liu G, Zhang Y, Zhang W, Dai Y, Jiang H, et al. The association between uric acid and erectile dysfunction: A systematic review and Meta-analysis. Andrologia 2021: e14319.
Zharikov S, Krotova K, Hu H, Baylis C, Johnson RJ, Block ER, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol 2008, 295(5): C1183-C1190.
Gersch C, Palii SP, Kim KM, Angerhofer A, Johnson RJ, Henderson GN. Inactivation of nitric oxide by uric acid. Nucleosides Nucleotides Nucleic Acids 2008, 27(8): 967-978.
Kang DH, Han L, Ouyang X, Kahn AM, Kanellis J, Li P, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005, 25(5): 425-433.
Tuokko AT, Murtola T, Korhonen P, Kaipia A. Hyperuricemia Is Not an Independent Predictor of Erectile Dysfunction. Sex Med 2021, 9(2): 100319.
Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010, 57(5): 804-814.
Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013, 381(9861): 153-165.
Muneer A, Kalsi J, Nazareth I, Arya M. Erectile dysfunction. BMJ 2014, 348: g129.
Lizza EF, Rosen RC. Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research. Int J Impot Res 1999, 11(3): 141-143.
Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, et al. Erectile dysfunction. Nat Rev Dis Primers 2016, 2: 16003.
Matsui H, Sopko NA, Hannan JL, Bivalacqua TJ. Pathophysiology of erectile dysfunction. Curr Drug Targets 2015, 16(5): 411-419.
Clark NG, Fox KM, Grandy S. Symptoms of diabetes and their association with the risk and presence of diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Diabetes Care 2007, 30(11): 2868-2873.
Quek KF, Sallam AA, Ng CH, Chua CB. Prevalence of sexual problems and its association with social, psychological and physical factors among men in a Malaysian population: a cross-sectional study. J Sex Med 2008, 5(1): 70-76.
Schulster ML, Liang SE, Najari BB. Metabolic syndrome and sexual dysfunction. Curr Opin Urol 2017, 27(5): 435-440.
Pernow J, Jung C. The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes. Curr Vasc Pharmacol 2016, 14(2): 155-162.
Ding F, Shan C, Li H, Zhang Y, Guo C, Zhou Z, et al. Simvastatin alleviated diabetes mellitus-induced erectile dysfunction in rats by enhancing AMPK pathway-induced autophagy. Andrology-Us 2020, 8(3): 780-792.
Julian TH, Syeed R, Glascow N, Zis P. Alcohol-induced autonomic dysfunction: a systematic review. Clin Auton Res 2020, 30(1): 29-41.
Lee AC, Ho LM, Yip AW, Fan S, Lam TH. The effect of alcohol drinking on erectile dysfunction in Chinese men. Int J Impot Res 2010, 22(4): 272-278.
Maiorino MI, Bellastella G, Esposito K. Lifestyle modifications and erectile dysfunction: what can be expected? Asian J Androl 2015, 17(1): 5-10.
Schulz KF. Randomized controlled trials. Clin Obstet Gynecol 1998, 41(2): 245-256.
Ranstam J. Bias in observational studies. Acta Radiol 2008, 49(6): 644-645.
Benedetto U, Head SJ, Angelini GD, Blackstone EH. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg 2018, 53(6): 1112-1117.
Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 2007, 26(1): 20-36.
Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 2008, 27(12): 2037-2049.
Salem S, Mehrsai A, Heydari R, Pourmand G. Serum uric acid as a risk predictor for erectile dysfunction. J Sex Med 2014, 11(5): 1118-1124.
Gao F, Jiang B, Cang Z, Wang N, Han B, Li Q, et al. Serum Uric Acid Is Associated with Erectile Dysfunction: A Population-Based Cross-Sectional Study in Chinese Men. Sci Rep 2017, 7(1): 2087.
Aribas A, Kayrak M, Ulucan S, Keser A, Demir K, Alibasic H, et al. The relationship between uric acid and erectile dysfunction in hypertensive subjects. Blood Press 2014, 23(6): 370-376.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993, 270(1): 83-90.
Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49(6): 822-830.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11(6): 319-326.
Wasserman MD, Pollak CP, Spielman AJ, Weitzman ED. The differential diagnosis of impotence. The measurement of nocturnal penile tumescence. JAMA 1980, 243(20): 2038-2042.
Bradley WE, Timm GW, Gallagher JM, Johnson BK. New method for continuous measurement of nocturnal penile tumescence and rigidity. Urology 1985, 26(1): 4-9.
Zou Z, Lin H, Zhang Y, Wang R. The Role of Nocturnal Penile Tumescence and Rigidity (NPTR) Monitoring in the Diagnosis of Psychogenic Erectile Dysfunction: A Review. Sex Med Rev 2019, 7(3): 442-454.
Barassi A, Corsi RM, Pezzilli R, Dozio E, Damele C, Vaccalluzzo L, et al. Levels of uric acid in erectile dysfunction of different aetiology. Aging Male 2018, 21(3): 200-205.
- Abstract Viewed: 490 times
- 8263/pdf Downloaded: 134 times